SCHEMBL6633816

SCHEMBL6633816

Cc1ccc(S(=O)(=O)N(c2ccc(OC(=O)N(C)C)cc2)[C@@](C)(C(=O)O)C(=O)C2CNCCN2)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
PTGES O14684 1/20 0.37
MAPT P10636 3/20 0.33
KDM4E B2RXH2 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PPARG P37231 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 3/20 0.32
TP53 P04637 2/20 0.32
HCRTR2 O43614 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
NPY2R P49146 1/20 0.31
MCL1 Q07820 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636214 0.91 ALDH1A1 (0.34) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6638193 0.86 ALDH1A1 (0.36) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6636510 0.83 ALDH1A1 (0.37) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6666837 0.78 RAB9A (0.36) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL6633703 0.78 ALDH1A1 (0.37) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6631786 0.78 ALDH1A1 (0.32) ALDH1A1PTGES
SCHEMBL6664426 0.77 ALDH1A1 (0.33) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6633734 0.77 ALDH1A1 (0.33) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6631913 0.76 ALDH1A1 (0.33) ALDH1A1PTGESMAPTKDM4EHSP90AA1
SCHEMBL6631970 0.75 TDP1 (0.35) ALDH1A1MAPTKDM4ERAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-B1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2004-05-19 EP claimed